Additional file 7 of Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer

Additional file 7: Supplementary Table 1. The IC50 values and RI values of NSCLC parental cells and CDDP resistant cells for 72 h. Supplementary Table 2 Antibody information. Supplementary Table 3 Primer Sequences